Drug comparisons
Acarbose vs Troglitazone
Acarbose (Precose) vs Troglitazone (Rezulin, withdrawn): Alpha-glucosidase inhibitor vs TZD. Troglitazone pulled for hepatotoxicity in 2000. Both oral antidiabetics.
No comparison dimensions are available for this page.
Clinical context
This comparison is relevant for historical or educational purposes regarding type 2 diabetes treatments, as Troglitazone is no longer on the market.
Bottom line
Acarbose remains an option for postprandial glucose control while Troglitazone is obsolete due to safety issues.
All medication comparisons